|
Volumn 35, Issue 11, 2009, Pages 1198-1199
|
Circulating CA125 and diffuse malignant peritoneal mesothelioma
|
Author keywords
CA125; Cytoreductive surgery; HIPEC; Hyperthermic intraperitoneal chemotherapy; Pattern of failure; Peritoneal mesothelioma
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CA 125 ANTIGEN;
MESOTHELIN;
ANTIGEN EXPRESSION;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER SURVIVAL;
CYTOREDUCTIVE SURGERY;
HUMAN;
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY;
LETTER;
PERITONEUM MESOTHELIOMA;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN BLOOD LEVEL;
SENSITIVITY AND SPECIFICITY;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CA-125 ANTIGEN;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
INFUSIONS, PARENTERAL;
MALE;
MESOTHELIOMA;
MIDDLE AGED;
PATIENT SELECTION;
PERITONEAL NEOPLASMS;
POSTOPERATIVE COMPLICATIONS;
SURVIVAL ANALYSIS;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 70349823875
PISSN: 07487983
EISSN: 15322157
Source Type: Journal
DOI: 10.1016/j.ejso.2009.04.007 Document Type: Letter |
Times cited : (18)
|
References (7)
|